Dyadic International, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; and sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-12upcoming | -0.04 | — | — |
| 2026-05-13 | -0.04 | -0.05 | -11.11% |
| 2026-03-25 | -0.04 | -0.06 | -33.33% |
| 2025-11-12 | -0.04 | -0.06 | -38.47% |
| 2025-08-13 | -0.06 | -0.06 | — |
| 2025-03-26 | -0.04 | -0.05 | -25.00% |
| 2024-11-12 | -0.07 | -0.01 | +85.71% |
| 2024-08-13 | -0.06 | -0.07 | -7.69% |
| 2024-03-28 | -0.06 | -0.08 | -23.08% |
| 2023-11-08 | -0.06 | -0.06 | — |
| 2023-08-09 | -0.05 | -0.07 | -40.00% |
| 2023-03-29 | -0.07 | -0.07 | — |
| 2022-11-10 | -0.09 | -0.06 | +36.84% |
| 2022-08-10 | -0.07 | -0.12 | -60.00% |
| 2022-05-12 | -0.14 | -0.09 | +35.71% |
| 2022-03-29 | -0.06 | -0.15 | -130.77% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| DYAI | +2.53% | +2.53% | -13.83% | -22.12% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -0.44% | +7.17% | -10.39% | -34.80% |